KTTA
Pasithea Therapeutics Corp
NASDAQ: KTTA · HEALTHCARE · BIOTECHNOLOGY
$0.69
+0.87% today
Updated 2026-04-30
Market cap
$17.21M
P/E ratio
—
P/S ratio
42.15x
EPS (TTM)
$-2.91
Dividend yield
—
52W range
$0 – $2
Volume
0.4M
Pasithea Therapeutics Corp (KTTA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
-200.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+64.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-3.4%
2026-02-25
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-0.89 | -394.4% | $0.87 | $0.84 | -3.4% |
| 2025-11-13 | $-0.41 | — | $0.70 | $0.72 | +2.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.18 | $-0.89 | -394.4% | — | — |
| 2025-09-30 | — | $-0.41 | — | — | — |
| 2025-06-30 | $0.00 | $-0.66 | — | — | — |
| 2025-03-31 | — | $-1.61 | — | — | — |
| 2024-12-31 | — | $-2.53 | — | $649028.00 | -33.5% |
| 2024-09-30 | — | $-2.87 | — | — | — |
| 2024-06-30 | — | $-3.71 | — | — | — |
| 2024-03-31 | — | $-3.70 | — | — | — |
| 2023-12-31 | $-0.19 | $-4.85 | -2450.8% | $976306.00 | — |
| 2023-09-30 | $-0.18 | $-0.14 | +20.2% | — | — |
| 2023-06-30 | $-0.17 | $-0.14 | +15.3% | — | — |
| 2023-03-31 | $-0.17 | $-0.17 | +0.0% | — | — |
Frequently asked questions
Has Pasithea Therapeutics Corp beaten earnings estimates?
Pasithea Therapeutics Corp has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports, with an average EPS surprise of -200.0% over the last 1 quarters.
How does KTTA stock react to earnings?
KTTA stock has moved an average of -0.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.